KCNAB1 Protein

KCNAB1 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNAB1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated potassium channel subunit beta-1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KCNAB1](/genes/kcnab1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q14721](https://www.uniprot.org/uniprot/Q14721)</td>
</tr>
<tr>
<td class="label">PDB IDs</td>
<td>1EXB, 1J02</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>38.7 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kv beta subunit (KCNAB)</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain ([hippocampus](/brain-regions/hippocampus), cortex), Heart, Pancreas</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KCNAB1 (Voltage-gated potassium channel subunit beta-1, also known as Kvβ1) is an auxiliary subunit of voltage-gated potassium (Kv) channels that plays a critical role in modulating neuronal excitability and synaptic transmission. This protein is implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Introduction

KCNAB1 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNAB1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated potassium channel subunit beta-1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KCNAB1](/genes/kcnab1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q14721](https://www.uniprot.org/uniprot/Q14721)</td>
</tr>
<tr>
<td class="label">PDB IDs</td>
<td>1EXB, 1J02</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>38.7 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kv beta subunit (KCNAB)</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain ([hippocampus](/brain-regions/hippocampus), cortex), Heart, Pancreas</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KCNAB1 (Voltage-gated potassium channel subunit beta-1, also known as Kvβ1) is an auxiliary subunit of voltage-gated potassium (Kv) channels that plays a critical role in modulating neuronal excitability and synaptic transmission. This protein is implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Introduction

KCNAB1 is a member of the Kv beta subunit family, which are cytoplasmic proteins that associate with the pore-forming alpha subunits of voltage-gated potassium channels. Unlike traditional ion channel subunits, Kv beta subunits do not form the ion-conducting pore themselves but instead modulate the gating kinetics, voltage dependence, and subcellular trafficking of their partner Kv alpha subunits.

The Kv beta subunits are essential for proper neuronal signaling because they provide a mechanism for fine-tuning potassium currents that regulate action potential repolarization, resting membrane potential, and synaptic integration. Dysregulation of these processes is increasingly recognized as a contributing factor in neurodegenerative disease progression.

Protein Overview

Structure

KCNAB1 is a cytosolic protein that assembles into homooligomers or heterooligomers with other Kv beta family members (KCNAB2, KCNAB3). The protein contains multiple functional domains:

• N-terminal Domain: Contains the binding site for Kv alpha subunits and determines subunit specificity
• Core Domain: Mediates oligomerization and forms the tetrameric assembly
• C-terminal Domain: Involved in interactions with accessory proteins and cellular signaling pathways

Normal Function

Potassium Channel Modulation

The Kv beta subunits regulate the gating kinetics, voltage dependence, and trafficking of voltage-gated potassium channels through several mechanisms:

Neuronal Physiology

In [neurons](/entities/neurons), Kv beta subunits regulate:

• Resting membrane potential
• Action potential duration and repolarization
• Repetitive firing frequency
• Synaptic integration and plasticity
• Dendritic integration of excitatory and inhibitory inputs

Role in Neurodegenerative Diseases

Alzheimer's Disease

KCNAB1 and other Kv beta subunits are implicated in Alzheimer's disease through several mechanisms[@connexin]:

• Neuronal Hyperexcitability: [Aβ](/proteins/amyloid-beta) oligomers disrupt Kv channel function, leading to increased neuronal excitability and calcium dysregulation
• Synaptic Dysfunction: Altered potassium currents contribute to synaptic loss and impaired plasticity
• Excitotoxicity: Dysregulated neuronal excitability can lead to glutamate-mediated excitotoxicity
• Mitochondrial Dysfunction: Kv channel dysfunction can affect mitochondrial calcium handling

Parkinson's Disease

In Parkinson's disease, KCNAB1 affects:

• Dopaminergic Neuron Survival: Proper Kv channel function is essential for the survival of substantia nigra dopaminergic neurons
• Motor Circuit Dysregulation: Altered neuronal excitability in the basal ganglia contributes to motor symptoms
• Oxidative Stress: Potassium channel dysfunction can exacerbate oxidative stress in dopaminergic neurons

Epilepsy

Given the central role of Kv channels in neuronal excitability, KCNAB1 dysfunction can contribute to seizure disorders. Mutations in KCNAB1 have been associated with epileptic phenotypes[@therapeutic].

Therapeutic Implications

Current Therapeutic Approaches

Research Directions

• Selective Modulators: Developing Kv beta subunit-selective modulators with improved specificity
• Combination Therapy: Targeting multiple ion channel subtypes simultaneously
• Disease-Modifying Approaches: Modulating Kv channel function to slow disease progression

Interactions and Pathways

KCNAB1 interacts with several proteins and participates in multiple signaling pathways:

• Kv Alpha Subunits: Kv1.1 (KCNA1), Kv1.2 (KCNA2), Kv1.5 (KCNA5)
• KCNAB Family: KCNAB2, KCNAB3
• Signaling Proteins: 14-3-3 proteins, PKA, PKC
• Cytoskeletal Proteins: Actin, Tubulin

Research Background

The study of Kv beta subunits began in the early 1990s with the identification of the first mammalian Kv beta subunit. Key discoveries include:

• 1993: Cloning of KCNAB1 cDNA
• 1997: Crystal structure determination
• 2000s: Links to neurological disorders established
• 2010s: Therapeutic potential recognized

Background

The study of Kcnab1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• KCNAB1 Gene
• [Ion Channel Dysfunction](/mechanisms/ion-channel-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Voltage-Gated Ion Channels](/mechanisms/ion-channel-dysfunction)
• [Neuronal Excitability](/mechanisms/neuronal-hyperexcitability)
• [Synaptic Transmission](/mechanisms/synaptic-dysfunction)

External Links

• [UniProt: Q14721](https://www.uniprot.org/uniprot/Q14721)
• [PDB: 1EXB, 1J02](https://www.rcsb.org/)
• [GeneCards: KCNAB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNAB1)

References